Invention Grant
US09458187B2 Methods for treatment of inflammatory conditions using S-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6α, 9α-difluoro-17α-(furan-2-yl) carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate
有权
使用S- [4-（3-糠基-3-甲基丁酰氧基）丁-2-炔基]6α，9α-二氟-17α-（呋喃-2-基）羰氧基-11β-羟基-16α- 甲基-3-氧代雄甾-1,4-二烯-17β-硫代磷酸酯
![Methods for treatment of inflammatory conditions using S-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6α, 9α-difluoro-17α-(furan-2-yl) carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate](/docs/US/2016-10-04/US09458187B2/abs.jpg.600x600.jpg)
- Patent Title: Methods for treatment of inflammatory conditions using S-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6α, 9α-difluoro-17α-(furan-2-yl) carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate
- Patent Title (中): 使用S- [4-（3-糠基-3-甲基丁酰氧基）丁-2-炔基]6α，9α-二氟-17α-（呋喃-2-基）羰氧基-11β-羟基-16α- 甲基-3-氧代雄甾-1,4-二烯-17β-硫代磷酸酯
-
Application No.: US14893655Application Date: 2014-05-28
-
Publication No.: US09458187B2Publication Date: 2016-10-04
- Inventor: Jiten Ranchhodbhai Patel , Gopalkumar Chimanlal Patel , Gaurav Sanjivkumar Sheth , Sanjay Nandlal Mandhane , Chitturi Trinadha Rao , Rajamannar Thennati
- Applicant: Sun Pharma Advanced Research Company Limited
- Applicant Address: IN Andheri (E), Mumbai
- Assignee: Sun Pharma Advanced Research Company Limited
- Current Assignee: Sun Pharma Advanced Research Company Limited
- Current Assignee Address: IN Andheri (E), Mumbai
- Agency: Schwegman Lundberg & Woessner, P.A.
- Priority: IN1881/MUM/2013 20130528
- International Application: PCT/IN2014/000359 WO 20140528
- International Announcement: WO2014/192027 WO 20141204
- Main IPC: C07J3/00
- IPC: C07J3/00 ; A61K31/56 ; C07J31/00
![Methods for treatment of inflammatory conditions using S-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6α, 9α-difluoro-17α-(furan-2-yl) carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate](/abs-image/US/2016/10/04/US09458187B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to methods of treatment of inflammatory conditions using S-[4-(3-fluoro-3-methylbutyryloxy)-but-2-ynyl]6α,9α-difluoro-17α-(furan-2-yl)carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate (compound of formula I), a novel anti-inflammatory compound of the androstane series and its processes of preparation.
Public/Granted literature
Information query
